Humana Inc. (NYSE:HUM) Shares Sold by Bartlett & CO. Wealth Management LLC

Bartlett & CO. Wealth Management LLC reduced its stake in shares of Humana Inc. (NYSE:HUM) by 1.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,052 shares of the insurance provider’s stock after selling 75 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in Humana were worth $1,287,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HUM. Stratos Wealth Advisors LLC grew its holdings in shares of Humana by 125.3% in the third quarter. Stratos Wealth Advisors LLC now owns 1,302 shares of the insurance provider’s stock valued at $412,000 after purchasing an additional 724 shares during the period. Trust Point Inc. lifted its holdings in Humana by 6.1% in the third quarter. Trust Point Inc. now owns 1,235 shares of the insurance provider’s stock valued at $391,000 after acquiring an additional 71 shares during the last quarter. Stonegate Investment Group LLC grew its position in Humana by 51.4% in the third quarter. Stonegate Investment Group LLC now owns 893 shares of the insurance provider’s stock worth $283,000 after acquiring an additional 303 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in Humana by 1.3% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,963 shares of the insurance provider’s stock worth $4,423,000 after acquiring an additional 179 shares during the last quarter. Finally, Bleakley Financial Group LLC raised its position in Humana by 14.8% in the third quarter. Bleakley Financial Group LLC now owns 1,841 shares of the insurance provider’s stock valued at $583,000 after purchasing an additional 237 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on HUM. Barclays lowered their price target on Humana from $364.00 to $250.00 and set an “equal weight” rating for the company in a report on Thursday, October 10th. TD Cowen downgraded shares of Humana from a “buy” rating to a “hold” rating and reduced their price target for the company from $402.00 to $261.00 in a research note on Monday, October 7th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a research report on Tuesday, October 1st. Royal Bank of Canada cut their target price on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Finally, UBS Group lowered their price target on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, October 4th. One analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $315.33.

Humana Trading Up 0.3 %

HUM opened at $267.14 on Friday. The business’s 50-day simple moving average is $315.89 and its 200-day simple moving average is $338.40. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market cap of $32.19 billion, a P/E ratio of 16.63, a PEG ratio of 1.91 and a beta of 0.50. Humana Inc. has a one year low of $213.31 and a one year high of $527.18.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping the consensus estimate of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period last year, the business earned $8.94 EPS. Humana’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities research analysts expect that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.